I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 20 studies | 25% ± 6% | |
| type I pneumocyte | 12 studies | 38% ± 10% | |
| type II pneumocyte | 12 studies | 62% ± 19% | |
| CD16-positive, CD56-dim natural killer cell, human | 12 studies | 28% ± 6% | |
| macrophage | 11 studies | 25% ± 10% | |
| non-classical monocyte | 8 studies | 19% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 8 studies | 24% ± 5% | |
| classical monocyte | 7 studies | 18% ± 4% | |
| retinal rod cell | 7 studies | 28% ± 7% | |
| retinal cone cell | 6 studies | 40% ± 16% | |
| endothelial cell | 5 studies | 25% ± 10% | |
| monocyte | 4 studies | 19% ± 1% | |
| neutrophil | 4 studies | 22% ± 4% | |
| mature NK T cell | 4 studies | 23% ± 7% | |
| club cell | 4 studies | 23% ± 5% | |
| epithelial cell | 4 studies | 19% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| microglial cell | 3 studies | 23% ± 11% | |
| abnormal cell | 3 studies | 18% ± 3% | |
| myeloid cell | 3 studies | 23% ± 1% | |
| gamma-delta T cell | 3 studies | 17% ± 1% | |
| glutamatergic neuron | 3 studies | 32% ± 12% | |
| neuron | 3 studies | 18% ± 3% |
